✦ LIBER ✦

Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial

✍ Scribed by Hauser, Robert A; Hsu, Ann; Kell, Sherron; Espay, Alberto J; Sethi, Kapil; Stacy, Mark; Ondo, William; O'Connell, Martin; Gupta, Suneel

Book ID: 120253543
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 233 KB
Volume: 12
Category: Article
ISSN: 1474-4465
DOI: 10.1016/S1474-4422(13)70025-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of levodopa/carbidopa/entacapon

Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial

✍ Tolosa, Eduardo; HernÃ¡ndez, Basilio; Linazasoro, Gurutz; LÃ³pez-Lozano, Juan Jo 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 445 KB

P2.092 A randomized, double-blind evalua

P2.092 A randomized, double-blind evaluation of levodopa/carbidopa/entacapone versus immediate-release levodopa/carbidopa in patients with Parkinson's disease exhibiting nonmotor symptoms of wearing off

✍ M. Stacy; K. Mccague; M. Weidenman; A. Campbell; M. Somogyi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Preladenant in patients with Parkinson's

Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial

✍ Robert A Hauser; Marc Cantillon; Emmanuelle Pourcher; Federico Micheli; Vincent 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 249 KB

Rasagiline as an adjunct to levodopa in

Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial

✍ O Rascol; DJ Brooks; E Melamed; W Oertel; W Poewe; F Stocchi; E Tolosa 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 122 KB

Tolerability of extended-release quetiap

Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study

✍ Peter Paul De Deyn; Hans Eriksson; Hanna Svensson; on behalf of the Study 115 in 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

## Objective The objective of this study was to assess the safety and tolerability of extended‐release quetiapine fumarate (quetiapine XR) compared with quetiapine immediate‐release (quetiapine IR) in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation. ## Methods